Mark Van Buskirk - Concepedia

Author

Mark Van Buskirk

Also Known As

Francesco Fiore, M van Buskirk, M. Van Buskirk, M. van Buskirk, Mark V. Buskirk, Mark Van Buskirk, Mark van Buskirk, Val Gebski

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Harm Reduction Services Northwestern Memorial Hospital Brookhaven College Johns Hopkins Hospital University Hospital Magdeburg

About

Mark Van Buskirk is an author at Harm Reduction Services specializing in radiation oncology, hepatology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	947
2	Hepatology	7	7	947
3	Health Sciences	5	5	427
4	Pathology	2	2	202
5	Radiation Medicine	1	1	34

Mark Van Buskirk

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation Bruno Sangro, L Carpanese, Roberto Cianni, Hepatology	2011	648
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma J.F. Geschwind, Riad Salem, Brian I. Carr, Gastroenterology HepatologyMedicineYttrium-90 MicrospheresLiver CancerLiver Transplantation	2004	352
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer Guy A. Van Hazel, Volker Heinemann, Navesh Sharma, Journal of Clinical Oncology	2016	339
Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model K.Peter Rentrop, John C. Thornton, Frederick Feit, The American Journal of Cardiology	1988	226
Treatment of Unresectable Hepatocellular Carcinoma with Intrahepatic Yttrium 90 Microspheres: Factors Associated with Liver Toxicities James E. Goin, Riad Salem, Brian I. Carr, Journal of Vascular and Interventional Radiology Intrahepatic Yttrium 90Liver ToxicitiesHepatologyMedicineHistopathology	2005	168
Left-Liver Hypertrophy After Therapeutic Right-Liver Radioembolization Is Substantial but Less Than After Portal Vein Embolization Benjamin Garlipp, Thierry de Baère, Robert Damm, Hepatology	2013	162
90Y Microsphere (TheraSphere) Treatment for Unresectable Colorectal Cancer Metastases of the Liver: Response to Treatment at Targeted Doses of 135–150 Gy as Measured by [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomographic Imaging Robert J. Lewandowski, Kenneth G. Thurston, James E. Goin, Journal of Vascular and Interventional Radiology Targeted DosesHepatologyGastrointestinal OncologyOncologic ImagingMedicine	2005	159
Treatment of Unresectable Hepatocellular Carcinoma with Intrahepatic Yttrium 90 Microspheres: A Risk-Stratification Analysis James E. Goin, Riad Salem, Brian I. Carr, Journal of Vascular and Interventional Radiology Intrahepatic Yttrium 90HepatologyHepatocellular CarcinomaMedicineHistopathology	2005	108
Hepatic Toxicity After Radioembolization of the Liver Using 90Y-Microspheres: Sequential Lobar Versus Whole Liver Approach Ricarda Seidensticker, Max Seidensticker, Robert Damm, CardioVascular and Interventional Radiology Liver Using 90Y-microspheresHepatologyLiver PhysiologyHepatobiliary TumorToxicology	2011	85
The impact of combining Selective Internal Radiation Therapy (SIRT) with Sorafenib on overall survival in patients with advanced hepatocellular carcinoma: The Soramic trial palliative cohort Jens Ricke, Bruno Sangro, Holger Amthauer, Journal of Hepatology HepatologyOverall SurvivalMedicineLiver CancerAdvanced Hepatocellular Carcinoma	2018	41

Page 1